Bausch + Lomb (BLCO) News Today $15.74 -0.15 (-0.91%) Closing price 03:59 PM EasternExtended Trading$15.88 +0.14 (+0.86%) As of 04:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Needham Sticks to Its Hold Rating for Bausch + Lomb Corporation (BLCO)February 21 at 5:44 PM | markets.businessinsider.comBausch + Lomb (NYSE:BLCO) Price Target Cut to $18.00 by Analysts at Royal Bank of CanadaRoyal Bank of Canada dropped their price target on Bausch + Lomb from $22.00 to $18.00 and set an "outperform" rating on the stock in a research note on Thursday.February 21 at 11:18 AM | marketbeat.comBank of America Issues Pessimistic Forecast for Bausch + Lomb (NYSE:BLCO) Stock PriceBank of America decreased their target price on shares of Bausch + Lomb from $18.00 to $17.00 and set an "underperform" rating for the company in a research report on Thursday.February 21 at 8:02 AM | marketbeat.comBausch + Lomb (NYSE:BLCO) Given "Hold" Rating at Needham & Company LLCNeedham & Company LLC reaffirmed a "hold" rating on shares of Bausch + Lomb in a research report on Thursday.February 21 at 8:02 AM | marketbeat.comBausch + Lomb (NYSE:BLCO) Announces Quarterly Earnings Results, Beats Estimates By $0.02 EPSBausch + Lomb (NYSE:BLCO - Get Free Report) announced its earnings results on Wednesday. The company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.02. Bausch + Lomb had a positive return on equity of 3.17% and a negative net margin of 7.86%.February 20 at 10:16 AM | marketbeat.comBausch + Lomb (NYSE:BLCO) Releases Earnings Results, Beats Expectations By $0.02 EPSBausch + Lomb (NYSE:BLCO - Get Free Report) announced its quarterly earnings data on Wednesday. The company reported $0.25 EPS for the quarter, beating the consensus estimate of $0.23 by $0.02. Bausch + Lomb had a negative net margin of 7.86% and a positive return on equity of 3.17%.February 20 at 8:40 AM | marketbeat.comBausch + Lomb Co. (NYSE:BLCO) Shares Bought by Alberta Investment Management CorpAlberta Investment Management Corp boosted its position in shares of Bausch + Lomb Co. (NYSE:BLCO - Free Report) by 36.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,008,193 shares of the company's stockFebruary 20 at 7:23 AM | marketbeat.comBausch + Lomb (NYSE:BLCO) Earns Buy Rating from HC WainwrightFebruary 20 at 1:59 AM | americanbankingnews.comHC Wainwright Lowers Earnings Estimates for Bausch + LombFebruary 20 at 1:23 AM | americanbankingnews.comBausch + Lomb price target lowered to $17 from $18 at StifelFebruary 20 at 12:23 AM | markets.businessinsider.comBausch + Lomb price target lowered to $17 from $18 at JPMorganFebruary 20 at 12:23 AM | markets.businessinsider.comBausch + Lomb Corporation (BLCO) Q4 2024 Earnings Call TranscriptFebruary 19 at 1:09 PM | seekingalpha.comBausch + Lomb reports Q4 adjusted EPS 25c, consensus 23cFebruary 19 at 10:13 AM | markets.businessinsider.comBausch + Lomb’s (NYSE:BLCO) Q4: Beats On RevenueFebruary 19 at 10:13 AM | msn.comBausch + Lomb's (BLCO) Buy Rating Reaffirmed at HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $23.00 price objective on shares of Bausch + Lomb in a report on Tuesday.February 19 at 8:20 AM | marketbeat.comHC Wainwright Decreases Earnings Estimates for Bausch + LombBausch + Lomb Co. (NYSE:BLCO - Free Report) - Analysts at HC Wainwright lowered their Q1 2025 EPS estimates for shares of Bausch + Lomb in a report released on Tuesday, February 18th. HC Wainwright analyst Y. Chen now expects that the company will earn $0.20 per share for the quarter, down from tFebruary 19 at 6:42 AM | marketbeat.comBausch + Lomb (BLCO) Reports Earnings Tomorrow: What To ExpectFebruary 18 at 9:51 AM | finance.yahoo.comBausch + Lomb Co. (NYSE:BLCO) Sees Significant Growth in Short InterestBausch + Lomb Co. (NYSE:BLCO - Get Free Report) was the target of a large growth in short interest during the month of January. As of January 31st, there was short interest totalling 1,730,000 shares, a growth of 37.3% from the January 15th total of 1,260,000 shares. Based on an average daily volume of 533,900 shares, the short-interest ratio is currently 3.2 days. Currently, 5.0% of the shares of the stock are short sold.February 15, 2025 | marketbeat.comBausch + Lomb (BLCO) Projected to Post Quarterly Earnings on WednesdayFebruary 12, 2025 | americanbankingnews.comBausch + Lomb (BLCO) to Release Quarterly Earnings on WednesdayBausch + Lomb (NYSE:BLCO) will be releasing earnings before the market opens on Wednesday, February 19, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=658180)February 12, 2025 | marketbeat.comBLCO Makes Notable Cross Below Critical Moving AverageFebruary 8, 2025 | nasdaq.comBausch + Lomb Corporation (BLCO) Stock ForecastsFebruary 7, 2025 | ca.finance.yahoo.comBausch + Lomb Corporation Stock Drops 8% After Privatization Effort EndsFebruary 6, 2025 | markets.businessinsider.comBausch Health cut to hold by Jefferies over B+L updateFebruary 6, 2025 | msn.comBausch + Lomb (NYSE:BLCO) Shares Gap Down - Here's What HappenedBausch + Lomb (NYSE:BLCO) Shares Gap Down - Here's WhyFebruary 6, 2025 | marketbeat.comBausch + Lomb beendet Verkaufsprozess und konzentriert sich auf Pläne für 2025February 6, 2025 | de.investing.comBausch + Lomb Provides Update on Potential SaleFebruary 6, 2025 | finance.yahoo.comBausch & Lomb drops after ending sales processFebruary 6, 2025 | seekingalpha.comRenaissance Capital LLC Raises Holdings in Bausch + Lomb Co. (NYSE:BLCO)Renaissance Capital LLC raised its position in Bausch + Lomb Co. (NYSE:BLCO - Free Report) by 116.2% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 94,182 shares of the company's stock after purchasing an additional 50,622 shares durinFebruary 4, 2025 | marketbeat.comSWOT-Analyse von Bausch + Lomb: Augenheilkunde-Aktie steht vor Herausforderungen und ChancenJanuary 30, 2025 | de.investing.comStifel Nicolaus Remains a Hold on Bausch + Lomb Corporation (BLCO)January 30, 2025 | markets.businessinsider.comBausch + Lomb's SWOT analysis: eye health stock faces challenges, opportunitiesJanuary 30, 2025 | msn.comBausch + Lomb Co. (NYSE:BLCO) Receives Average Recommendation of "Hold" from BrokeragesShares of Bausch + Lomb Co. (NYSE:BLCO - Get Free Report) have earned an average rating of "Hold" from the thirteen research firms that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating aJanuary 30, 2025 | marketbeat.com3 Hidden Bargains in the Healthcare SectorJanuary 29, 2025 | stocknews.comRBC Capital Issues a Buy Rating on Bausch + Lomb Corporation (BLCO)January 29, 2025 | markets.businessinsider.comRoyal Bank of Canada Lowers Bausch + Lomb (NYSE:BLCO) Price Target to $22.00Royal Bank of Canada lowered their price objective on Bausch + Lomb from $23.00 to $22.00 and set an "outperform" rating for the company in a research note on Wednesday.January 29, 2025 | marketbeat.comBausch + Lomb (NYSE:BLCO) Price Target Lowered to $18.00 at Stifel NicolausStifel Nicolaus lowered their price objective on shares of Bausch + Lomb from $19.00 to $18.00 and set a "hold" rating for the company in a research report on Wednesday.January 29, 2025 | marketbeat.comMorgan Stanley Keeps Their Hold Rating on Bausch + Lomb Corporation (BLCO)January 24, 2025 | markets.businessinsider.comThis Bausch + Lomb Insider Increased Their Holding In The Last YearJanuary 21, 2025 | finance.yahoo.comBausch + Lomb price target raised to $19 from $18 at BarclaysJanuary 21, 2025 | markets.businessinsider.comEllsworth Advisors LLC Takes Position in Bausch + Lomb Co. (NYSE:BLCO)Ellsworth Advisors LLC acquired a new stake in shares of Bausch + Lomb Co. (NYSE:BLCO - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 36,844 shares of the company's stock, valuedJanuary 20, 2025 | marketbeat.comBausch + Lomb Corporation (BLCO) Receives a Buy from Wells FargoJanuary 16, 2025 | markets.businessinsider.comBausch + Lomb (NYSE:BLCO) Given New $24.00 Price Target at Wells Fargo & CompanyWells Fargo & Company dropped their price objective on shares of Bausch + Lomb from $26.00 to $24.00 and set an "overweight" rating on the stock in a research report on Thursday.January 16, 2025 | marketbeat.comBausch + Lomb launches enVista Aspire monofocal, toric intraocular lenses in EUJanuary 14, 2025 | markets.businessinsider.comBausch + Lomb unit acquires Whitecap Biosciences, terms undisclosedJanuary 14, 2025 | markets.businessinsider.comBausch + Lomb Buys Pharma Company Whitecap BiosciencesJanuary 13, 2025 | marketwatch.comBausch + Lomb Launches enVista Aspire™ Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European UnionJanuary 13, 2025 | finance.yahoo.comBausch + Lomb Bolsters Pipeline with Acquisition of Whitecap BiosciencesJanuary 13, 2025 | finance.yahoo.comIs Bausch + Lomb (BLCO) the Best Medical Stock to Buy Under $20?January 12, 2025 | msn.comWells Fargo Sticks to Its Buy Rating for Bausch + Lomb Corporation (BLCO)January 11, 2025 | markets.businessinsider.com Get Bausch + Lomb News Delivered to You Automatically Sign up to receive the latest news and ratings for BLCO and its competitors with MarketBeat's FREE daily newsletter. Email Address BLCO Media Mentions By Week BLCO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BLCO News Sentiment▼0.190.60▲Average Medical News Sentiment BLCO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BLCO Articles This Week▼265▲BLCO Articles Average Week Get Bausch + Lomb News Delivered to You Automatically Sign up to receive the latest news and ratings for BLCO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Zimmer Biomet News Today Solventum News Today Smith & Nephew News Today Penumbra News Today Glaukos News Today Stevanato Group News Today Inspire Medical Systems News Today Inari Medical News Today Envista News Today PROCEPT BioRobotics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BLCO) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch + Lomb Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bausch + Lomb With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
